Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

59
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
59
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

99
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
99
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

132
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
132
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

54
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
54
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

2.7K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.7K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

53
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
53

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biaxial biomechanics of aged human carotid arteries.

Journal of the mechanical behavior of biomedical materials·2026
Same author

Central Systolic Blood Pressure and Left Ventricular Mass: Findings From the International 24-Hour Aortic Blood Pressure Consortium.

Journal of the American Heart Association·2026
Same author

Novel hypertension phenotypes based on cross-classification of 24-h brachial and aortic SBP.

Journal of hypertension·2026
Same author

Tonometer- and ultrasound-based pulse wave analysis - a comparative study.

Computer methods and programs in biomedicine·2026
Same author

Integrating Structural and Functional Ultrasound Carotid Assessment in a Single Software Platform: Development and Feasibility Evaluation.

Ultrasound in medicine & biology·2026
Same author

Central pulsatile haemodynamics in COPD: a propensity score-matched evaluation of cohorts.

ERJ open research·2026

Related Experiment Video

Updated: Sep 27, 2025

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
05:51

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness

Published on: May 3, 2018

17.8K

Covid-19 Effects on ARTErial StIffness and Vascular AgeiNg: CARTESIAN Study Rationale and Protocol.

Rosa Maria Bruno1, Bart Spronck2,3, Bernhard Hametner4

  • 1INSERM U970 Team 7, Paris Cardiovascular Research Centre - PARCC, University Paris Descartes, AP-HP, Pharmacology Unit, Hôpital Européen Georges Pompidou, 56 Rue Leblanc, Paris 75015, France.

Artery Research
|April 13, 2022
PubMed
Summary

The CARTESIAN study investigates how COVID-19 impacts vascular ageing, assessing early vascular ageing (EVA) markers six and twelve months post-infection. This research aims to understand COVID-19

Keywords:
COVID-19arterial stiffnesscoronavirusinflammationvascular ageing

More Related Videos

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound
10:08

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound

Published on: December 2, 2014

16.2K
Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy
10:35

Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy

Published on: October 19, 2016

10.7K

Related Experiment Videos

Last Updated: Sep 27, 2025

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
05:51

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness

Published on: May 3, 2018

17.8K
Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound
10:08

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound

Published on: December 2, 2014

16.2K
Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy
10:35

Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy

Published on: October 19, 2016

10.7K

Area of Science:

  • Cardiovascular Medicine
  • Infectious Diseases
  • Vascular Biology
  • Epidemiology

Background:

  • COVID-19, a novel coronavirus pneumonia, has caused a global pandemic since December 2019.
  • While primarily respiratory, COVID-19 significantly affects the cardiovascular system.
  • The long-term vascular consequences of COVID-19 remain largely uncharacterized.

Purpose of the Study:

  • To evaluate the presence of Early Vascular Ageing (EVA) 6 and 12 months after COVID-19 infection.
  • To assess the impact of COVID-19 disease severity on EVA.
  • To explore the influence of psychosocial factors, comorbidities, and treatments on COVID-19-induced EVA.

Main Methods:

  • The CARTESIAN study is the first international multicentre initiative on COVID-19's effects on vascular ageing biomarkers.
  • Utilizes non-invasive cardiovascular measurements: carotid-femoral pulse wave velocity, central blood pressure, carotid ultrasound, and brachial flow-mediated dilatation.
  • Enrolls over 2500 individuals across 43 centers in 21 countries.

Main Results:

  • This section is to be filled upon study completion.

Conclusions:

  • The CARTESIAN study will provide novel insights into the relationship between COVID-19, disease severity, and early vascular ageing.
  • Findings may inform future diagnostic and care strategies, focusing on vulnerable populations.
  • Establishes a large cohort for understanding post-COVID-19 vascular health.